Found: 9
Select item for more details and to access through your institution.
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37113-5
- By:
- Publication type:
- Article
Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37112-6
- By:
- Publication type:
- Article
Review of the Existing Translational Pharmacokinetics Modeling Approaches Specific to Monoclonal Antibodies (mAbs) to Support the First-In-Human (FIH) Dose Selection.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 12754, doi. 10.3390/ijms232112754
- By:
- Publication type:
- Article
Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 10, p. 1393, doi. 10.1007/s00228-020-02929-6
- By:
- Publication type:
- Article
Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 3, p. 585, doi. 10.1093/jac/dkn544
- By:
- Publication type:
- Article
Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 3, p. 481, doi. 10.1007/s40262-023-01216-8
- By:
- Publication type:
- Article
Randomized study of the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 11, p. 2174, doi. 10.1111/bcp.14309
- By:
- Publication type:
- Article
Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 6, p. 565, doi. 10.1007/s40262-014-0136-3
- By:
- Publication type:
- Article
Translation of Monoclonal Antibodies Pharmacokinetics from Animal to Human Using Physiologically Based Modeling in Open Systems Pharmacology (OSP) Suite: A Retrospective Analysis of Bevacizumab.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 8, p. 2129, doi. 10.3390/pharmaceutics15082129
- By:
- Publication type:
- Article